# Impact of Built-In Software Monitoring on Survival in Amyotrophic Lateral Sclerosis Patients Receiving Home Mechanical Ventilation: A Cohort Study

**Authors:** Ana Hernández-Voth, Javier Sayas-Catalán, Marta Corral-Blanco, Miguel Jiménez-Gómez, Gema Carvajal-Cuesta, Manel Luján-Torné, Cristina Lalmolda-Puyol, Pablo Florez-Solarana, Victoria Villena-Garrido

PMC · DOI: 10.3390/jcm15041513 · 2026-02-14

## TL;DR

Using built-in ventilator software monitoring in ALS patients on home ventilation is linked to longer survival and better outcomes.

## Contribution

This study shows that built-in ventilator software monitoring improves survival in ALS patients receiving home mechanical ventilation.

## Key findings

- ALS patients using detailed built-in ventilator software had significantly longer survival from diagnosis and from ventilation initiation.
- Greater daily mechanical ventilation usage was associated with shorter survival.
- Patients with the lowest proportion of spontaneous inspirations had better survival outcomes.

## Abstract

Background/Objectives: Amyotrophic lateral sclerosis is a progressive neurodegenerative disease in which respiratory failure is the leading cause of death. Mechanical ventilation improves both survival and quality of life; however, the prognostic implications of built-in ventilator software monitoring remain insufficiently characterized. The aim of the study was to determine whether built-in ventilator software-based monitoring is associated with enhanced survival in amyotrophic lateral sclerosis subjects. Methods: Cohort study of amyotrophic lateral sclerosis subjects, stratified into two groups: those monitored through detailed built-in ventilator software and those not monitored. Clinical and ventilatory data were systematically evaluated during a 24-month follow-up. Results: Among 120 ALS subjects (57 detailed built-in ventilator software, 63 non-detailed ventilator software), median survival from diagnosis was significantly longer in the detailed built-in ventilator software group (3.42 vs. 2.12 years; p < 0.001). Survival from mechanical ventilation initiation was also significantly longer in the built-in ventilator software group (2.79 years vs. 0.78 years). Greater daily mechanical ventilation usage was associated with shorter survival (p < 0.003). Paradoxically, subjects with the lowest proportion of spontaneous inspirations exhibited superior survival outcomes (p = 0.04). Neither persistent leaks nor asynchronies were independently predictive of survival. Conclusions: BVS-monitoring was associated with improved survival in amyotrophic lateral sclerosis subjects receiving home mechanical ventilation. Its integration into clinical practice may enable timely, data-driven ventilatory adjustments, ultimately contributing to more individualized and optimized patient management.

## Linked entities

- **Diseases:** Amyotrophic lateral sclerosis (MONDO:0004976)

## Full-text entities

- **Diseases:** functional impairment (MESH:D003072), bulbar dysfunction (MESH:D010244), ALS (MESH:D008113), BVS (MESH:D053717), obstructions (MESH:D000402), frontotemporal dementia (MESH:D057180), neuromuscular disease (MESH:D009468), hypopnea (MESH:D012891), fatigue (MESH:D005221), apnea-hypopnea (MESH:D020181), respiratory failure (MESH:D012131), primary lateral sclerosis (MESH:D016472), decompensation (MESH:D006333), progressive muscular atrophy (MESH:D009134), leak (MESH:D019559), infections (MESH:D007239), COVID-19 (MESH:D000086382), death (MESH:D003643), hypoventilation (MESH:D007040), apnea (MESH:D001049), degenerative disorder (MESH:D019636), injury to (MESH:D014947), ALS (MESH:D000690)
- **Chemicals:** creatinine (MESH:D003404), carbon dioxide (MESH:D002245), BVS (-)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12941714/full.md

---
Source: https://tomesphere.com/paper/PMC12941714